A<sub>3</sub> Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity

A<sub>3</sub> Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity

The overexpression of the A<sub>3</sub> adenosine receptor (AR) in a number of cancer cell types makes it an attractive target for tumor diagnosis and therapy. Hence, in the search for new A<sub>3</sub>AR ligands, a series of novel 2,<i>N</i><sup>6</sup&g...

Full description

Bibliographic Details
Main Authors: Andrea Spinaci, Michela Buccioni, Diego Dal Ben, Federica Maggi, Gabriella Marucci, Beatrice Francucci, Giorgio Santoni, Catia Lambertucci, Rosaria Volpini
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Pharmaceuticals
Subjects:
A<sub>3</sub> adenosine receptors
A<sub>3</sub> adenosine receptor antagonists
adenosine derivatives
anticancer activity
sulforhodamine B assay
Online Access:https://www.mdpi.com/1424-8247/15/2/164

Internet

https://www.mdpi.com/1424-8247/15/2/164

Similar Items